| 000 | 01765 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518082843.0 | ||
| 264 | 0 | _c20201016 | |
| 008 | 202010s 0 0 eng d | ||
| 022 | _a1090-2104 | ||
| 024 | 7 |
_a10.1016/j.bbrc.2020.01.081 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNohara, Hirofumi | |
| 245 | 0 | 0 |
_aIntratracheal GLP-1 receptor agonist treatment up-regulates mucin via p38 and exacerbates emphysematous phenotype in mucus hypersecretory obstructive lung diseases. _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _c04 2020 |
||
| 300 |
_a332-339 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aExenatide _xadverse effects |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide-1 Receptor _xmetabolism |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 |
_aLung Diseases, Obstructive _xdrug therapy |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMucins _xgenetics |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xmetabolism |
| 650 | 0 | 4 | _aGlucagon-Like Peptide-1 Receptor Agonists |
| 700 | 1 | _aNakashima, Ryunosuke | |
| 700 | 1 | _aKamei, Shunsuke | |
| 700 | 1 | _aFujikawa, Haruka | |
| 700 | 1 | _aUeno-Shuto, Keiko | |
| 700 | 1 | _aKawakami, Taisei | |
| 700 | 1 | _aEto, Yuka | |
| 700 | 1 | _aSuico, Mary Ann | |
| 700 | 1 | _aLi, Jian-Dong | |
| 700 | 1 | _aKai, Hirofumi | |
| 700 | 1 | _aShuto, Tsuyoshi | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 524 _gno. 2 _gp. 332-339 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbrc.2020.01.081 _zAvailable from publisher's website |
| 999 |
_c30574521 _d30574521 |
||